AI is starting to resolve shipment exceptions and flag demand shifts, but early deployments show that connected data and context come first and that accountability stays with people.
Commentary|Podcasts|February 27, 2026
Cybersecurity and AI in the Era of Home-Based Care Logistics
A conversation with Kenco’s Tim McClatchy explores how pharmaceutical logistics providers are strengthening cybersecurity across manufacturer-to-home delivery networks, deploying AI to optimize operations, and adapting to evolving regulatory pressures shaping the future of healthcare supply chains.
Advertisement
In this exclusive PC Podcast interview, Tim McClatchy, Kenco’s vice president of life sciences at Kenco, a third-party logistics provider (3PL), discusses:
- Specific cybersecurity controls and verification processes used to protect shipment data and patient-related information across manufacturer, 3PL, and final-mile delivery handoffs
- The logistics functions that are currently supported by AI or predictive analytics (such as labor planning or route optimization)
- Recent regulatory changes that required Kenco to adjust healthcare logistics operations, and operational steps that were taken to maintain compliance without disrupting service
- Level of impact he anticipates 3PLs and their role within the industry having over the course of the next decade
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Advertisement
Related to this article
Cencora's Matt Sample explains how AI compares forecasts with ordering patterns to flag pharma demand shifts early, with 10% forecasting gains.
At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.
LogiPharma's Charleen Ring and McKesson's Chris Van Norman preview the 2026 agenda, sessions to prioritize and a day two fireside chat.
Zoomlogi's Henry Ames explains how AI agents and digitized SOPs help quality managers decide on quarantine or release after a cold chain excursion.
Zoomlogi’s Henry Ames says exception handling still hinges on experienced staff, and AI agents could gather and document details for their judgment calls.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FAQ: How Is AI Being Deployed in Pharma Supply Chains?
2
Epic, Amazon, Cost Plus Announce Point-of-Care Cash Price Tool
3
BioPharma Supply Chains of the Future: What to Know About Localization
4
How AI Agents Speed Quality Decisions After a Cold Chain Excursion
5